Availability of purified recombinant (r) murine MIP-l a , MIP-I@, and MIP-2 made possible an evaluation of the effects of recombinantly derived proteins on myeloid colony formation in vitro. The studies presented here demonstrate that each of the three recombinant preparations enhance colony formation of murine and human bone marrow CFU-GM, confirming the roles attributed to the natural proteins.' Moreover, it was found that natural MIP-1 and rMIP-la, but not rMIP-I@ or rMIP-2, suppress colony formation by an apparently earlier, more immature, set of progenitor cells.
MATERIALS AND METHODS
Femoral bone marrow cells were obtained from 4-to 6-week-old (C57B1/6 x DBA/2)FI (BDF,) female mice purchased from Cumberland View Farms (Clinton, TN). Cells were used as isolated. Human bone marrow cells were obtained by aspiration from the posterior iliac crest of healthy volunteers who had given informed consent. Low density cells (<1.077 g/cm3) were retrieved after density cut separation on Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ). Human bone marrow was further enriched for hematopoietic progenitor cells by obtaining fractions of nonadherent low-density T lymphocytedepleted fluorescence-activated cell-sorted CD34+ + +HLA-DR+ cells, as described by us previously,8 using a Coulter 753 Flow Cytometry System (Hialeah, FL), except that we sorted for the highest density of CD34+++ cells, which represents approximately 1% of the starting population of nonadherent low-density T lymphocytedepleted cells. This allowed increased enrichment of hematopoietic progenitor cells compared with our previous report.* Biomolecules and antibodies. Natural murine (mu) MIP-1 (comprised of a and fl peptides) and MIP-2 were isolated from the supernatant fluid of lipopolysaccharide (LPS)-stimulated RAW 264.7 cells: and rmu MIP-la, MIP-lfl, and MIP-2 were expressed in Saccharomyces cerevisiae and purified to homogeneity according to methods established for the natural We also used rMIP-la from T lymphocytes. Kwon et a1 reported a cDNA sequence, L2G25B isolated from T lymphocytes, that is identical to the MIP-la cDNA.~.'' The recombinant L2G25B protein, a T cell-derived MIP-la, was produced using a bovine papilloma virus expression system. The protein was purified through Q-Sepharose (Pharmacia), preparatieSDS-polyacrylamide gel, and SDS-buffer For personal use only. on September 24, 2017. by guest www.bloodjournal.org From elution method." The final product was dissolved in 6 mol/L guanidine HCI and renaturated." Recombinant MIP-la from macrophage and T lymphocyte derivation were equally active. Recombinant preparations of mu and human (hu) GM-CSF" (each lo* CFU/mg) were gifts from Drs Steven Gillis and David Urdal (Immunex Corp, Seattle, WA). Natural mu M-CSF (2.3 x lo7 U/mg)I2 was a gift from Dr Richard K. Shadduck (University of Pittsburgh School of Medicine, Pittsburgh, PA). Recombinant huM-CSF (lot DCP-006, from the long form) was a gift from Dr Peter Ralph (Cetus Corp, Emeryville, CA). Pokeweed mitogen spleen-conditioned medium (PWMSCM) was prepared as described." The purified immunoglobulin (Ig) fractions of anti-MIP-1 and anti-MIP-2'' were prepared from serum of rabbits injected respectively with purified preparations of natural (n) muMIP-1 and nmuMIP-2.
Colony assays: Colony-forming unit-granulocyte-macrophage.
Unseparated mouse bone marrow cells were plated at 7.5 x lo4 cells/mL in 0.3% agar (Difco Laboratories, Inc, Detroit, MI) culture medium with purified growth factors or 10% vol/vol PWMSCM.7,'2 Low-density human bone marrow cells were plated at lo5 cells/mL as de~cribed,~.'~ except that 0.4% Sea Plaque Agarose (FMC BioProducts, Rockland, ME)' was used instead of agar as the semisolid support medium. Agarose in the human assay allows detection of macrophage colonies (50 to ~5 0 0 cells/colony) stimulated by rhuM-CSF, while also allowing detection of GM c~lonies.'~ Cultures were incubated at lowered (5%) 0, tension7.I2 in an ESPEC N2-0,-C02 incubator BNP-210 (Tabai ESPEC Corp, South Plainfield, NJ) with mouse and human cells scored after 7 and 14 days of incubation, respectively, for colonies ( 2 5 0 cells) and clusters (5 to 50 cells). Colony and cluster morphology was assessed as b e f~r e .~ Burst-forming unii-erythroid and colony-forming unii-granulocyte-erythroid-macrophage-megakaryocyte. Unseparated mouse bone marrow cells were plated at 7.5 x lo4 cells/mL and low-density human bone marrow cells were plated at lo5 cells/mL in 1.3% methylcellulose with 1 U/mL rEpo (Amgen Corp, Thousand Oaks, CA) with or without other growth factor^.^"^ CD34+ ++HLA-DR+ cells were plated at 300 cells/mL, and CFU-GM colonies and clusters were also scored from these plates. Cultures were incubated as above and scored for mouse and human colonies after 7 and 14 days of incubation, respectively.
Results are expressed as mean f 1 SEM of three plates per point for CFU-GM and four plates per point for BFU-E. Levels of significance were determined using student's t distribution.
Statistics.

RESULTS
Myelopoietic enhancing activities on murine and human colony-forming unit-granulocyte macrophage. Recombinant MIP-la, MIP-10, and MIP-2 were assessed, in comparison with nMIP-1, for effects on colony and cluster formation of mouse marrow CFU-GM stimulated with nmuM-CSF or rmuGM-CSF. A dose-titration study, shown in Table 1 (one representative of two similar experiments), demonstrated that 400 ng/mL of rMIP maximally enhanced CSF-stimulated colony formation. Recombinant MIP-a appeared, on a weight basis, to be slightly less active than rMIP-10 or rMIP-2. The average results of five to seven experiments using 400 ng rMIP are shown in Table 2 . Enhancement in colony and cluster numbers with rMIP-la, rMIP-10, and rMIP-2 was similar to that noted with nMIP-1 (200 ng/mL). Combination of rMIP-la (100 to 400 ng/mL) with similar concentrations of rMIP-10 or rMIP-2 did not further enhance colony or cluster formation (data not shown). Colonies and clusters stimulated with M-CSF were greater than 95% composed of macrophages; those stimulated with GM-CSF were greater than 50% composed of granulocytes plus macrophages, with or without MIPS. As shown in Table  3 , anti-MIP-1 neutralized the myelopoietic enhancing activities of nMIP-1, rMIP-la, and rMIP-l/3, but not that of rMIP-2, and anti-MIP-2 neutralized the myelopoietic enhancing activity of rMIP-2, but not those of nMIP-1, For personal use only. on September 24, 2017. by guest www.bloodjournal.org From 
rMIP-2 (400 ng/mL)
A total of 7. rMIP-la, or rMIP-lp, suggesting that the enhancing activities of rMIP-1 and rMIP-2 were independent and not due to contaminating molecules. It had previously been determined that the natural murine preparations of MIPs were active on human cells.' To determine if the recombinant MIP preparations were also active on human cells, rMIP-la, rMIP-18, and rMIP-2 (400 ng/mL each) were assessed in comparison with nMIP-1 (200 ng/mL) for effects on colony and cluster formation by human bone marrow CFU-GM stimulated with suboptimal amounts of rhuM-CSF (200 U/mL) or rhuGM-CSF (20 U/mL) or with optimal amounts of rhu interleukin-3 (IL-3) (200 U/mL). As seen in Table 4 , natural and rMIPs enhanced human marrow colony formation. However, when maximally stimulating concentrations of rhuM-CSF (2,000 U/mL) or rhuGM-CSF (200 U/mL) were used, variability in response to the MIP preparations was noted. Colony formation was enhanced by 33% to 60% (P < .01) in one experiment with each MIP preparation, while no significant changes were seen with these same preparations of MIPs in two other experiments (data not shown).
Suppressing activity on subpopulations of myeloid progenitors. Bone marrow contains a hierarchy of overlapping myeloid progenitor cells at different stages of maturity.'*'' Colony-forming unit-GEMMs are considered earlier cells than BFU-E or CFU-GM, and differing stages of maturity exist within the BFU-E and CFU-GM compartments." Combinations of CSFs can act in an additive or synergistic manner, allowing detection of earlier progenitor cell^.'^*^'^ For example, Epo plus IL-3 or GM-CSF stimulates the CFU-GEMM, as well as a subpopulation of BFU-E not detected with Epo alone. Natural MIP-I, rMIP-la, rMIP-18, and rMIP-2, at concentrations that optimally enhanced colony formation in the above-mentioned experiments, were thus assessed for effects on human CFU-GEMM and BFU-E stimulated by Epo in the absence or presence of rhuIL-3 or For --A total of lo5 low-density notmal human bone marrow cells were plated in methylcellulose. 8.0 k 1.3. The suppressive effects of nMIP-1 and rMIP-la were completely neutralized by preincubation of these preparations with anti-MIP-1 antibodies. Recombinant MIP-la (400 ng/mL) reduced BFU-E/CFU-GEMM colonies stimulated with 1 U Epo plus 200 U rhuIL-3 from control numbers of 95 k 5/4.5 k 0.5 to 37 k 2/0. Preincubation of rMIP-la with anti-MIP-1 ablated the suppressive effect (95 k 1/ 4.5 k OS), while preincubation of rMIP-la with anti-MIP-2 did not ablate the suppression (40 k l/O). Anti-MIP-1 and anti-MIP-2 by themselves had no effect on colony formation (85 k 514.5 5 0.5 and 95 k 2/5 * 0, respectively). In the presence of Epo and the absence of rhuIL-3, BFU-E/CFU-GEMM numbers were 52 k 3/0. None of the preparations of MIP influenced BFU-E colony formation stimulated only in the presence of Epo (Table 5) , a result consistent with our previous studies using mouse BFU-E.' Also, natural MIP-1 and rMIP-la, but not rMIP-10 or rMIP-2, suppressed human CFU-GM colonies stimulated with 200 U rhuGM-CSF plus 200 U rhuIL-3/mL. Colonies stimulated by this combination of CSFs were 67 2 1, 37 f 5, 31 + 2, 63 k 2, and 65 k 4, respectively, when plated in the presence of control medium, 200 ng mMIP-1,400 ng rMIP-la, 400 ng rMIP-10, and 400 ng rMIP-2/mL. Without the addition of MIP, the number of colonies stimulated by rhuGM-CSF plus rhuIL-3 in the presence of control medium (67 * 1) was greater than the additive effects of rhuGM-CSF (26 f 1) and rhuIL-3 (11 k 1). A similar pattern of suppressive activity for nMIP-1 and rMIP-la was seen when mouse bone marrow CFU-GMs were stimulated with PWMSCM, which contains GM-CSF, IL-3, M-CSF, as well as other growth factors, and when BFU-E and CFU-GEMM were stimulated with Epo plus PWMSCM (Table 6) .
rhuGM-CSF (Table 5, 3 experiments). Natural MIP-1 and rMIP-la, but not rMIP-10 or rMIP-2, suppressed all the rhuIL-3-and rhuGM-CSF-enhanced BFU-E colony formation beyond that seen in the presence of only Epo
To determine whether the suppressive effects of MIP-la might be directly acting on the progenitors themselves, nMIP-1 and rMIP-la were evaluated in comparison with nMIP-2 for effects on a population of 300 non-adherent, low density, T-lymphocyte depleted (NALT-) CD34+++HLA-DR+ cell-sorted normal human bone marrow cells per milliliter highly enriched for hematopoietic progenitors (Table 7). In three experiments, the cloning efficiency of these cells ranged from 42% to 75% for BFU-E plus CFU-GM and CFU-GEMM (see legend to Table 7 ). Natural MIP-1 and rMIP-la, but not nMIP-2, suppressed colony formation of BFU-E stimulated with Epo plus rhuIL-3 or rhuGM-CSF. The MIP preparations had no effect on BFU-E stimulated only in the presence of Epo. Not shown in Table 7 is that nMIP-1 and rMIP-la, but not nMIP-2, also suppressed CFU-GEMM colony formation by these enriched cells. For example, CFU-GEMM colonies were 6.3 k 0.9, 2.3 2 0.3 (P < .05), 1 .0 k 0.6 (P c; .001), and 6.3 k 0.9, respectively, in the presence of control medium, nMIP-1, rMIP-la, and rMIP-2 when cells were stimulated with Epo plus GM-CSF. Without GM-CSF, no CFU-GEMM colonies were detected. The nMIP-1 and rMIP-2, but not nMIP-2, also suppressed rhuGM-CSF plus rhuIL-3-stimulated CFU-GM colony plus cluster formation of these cells by 44% to 68% (P < .001 to P < .0001). These results suggest direct-acting suppressive effects of nMIP-1 and rMIP-la on BFU-E, CFU-GEMM, and CFU-GM.
DISCUSSION
The present studies substantiate the murine and human myelopoietic enhancing activities of muMIPs' using purified rMIP, and demonstrate that both MIP-la and MIP-10, as well as MIP-2, have this capability, a fact confirmed by the ability to neutralize the activities of the recombinant proteins with their respective antibodies. The enhancing effects, as previously described using only nMIP-1 and nMIP-2,' are more apparent when progenitor cells are stimulated in the presence of suboptimal concentrations of M-CSF and GM-CSF. Using purified preparations of muCFU-GM and nMIP, we had previously demonstrated that this enhancing activity was a direct-acting one on CFU-GM,' although the mechanism of this enhancement is unknown. We have not ruled out that these MIP preparations can act also in an indirect, accessory cell-mediated manner to enhance progenitor cell proliferation.
It is now apparent that MIP-la is selective, at least in terms of concentration, in relation to the other species of MIPS, in its ability to suppress growth factor-stimulated proliferation of CFU-GEMM and subpopulations of BFU-E and CFU-GM. These effects are also apparently directacting ones on progenitors, as suggested by our studies using highly enriched progenitor cells, but, again, we cannot rule A total of 7.5 x lo4 mouse cells were plated in agar for CFU-GM assay or in methylcellulose for 8FU-E/CFU-GEMM assays. out the possibility that MIP-la might also have indirect accessory cell-mediated suppressive cell activities. Since CFU-GEMMs are early progenitor cells that give rise to BFU-E and CFU-GM," and the subpopulations of BFU-E and CFU-GM that are suppressed are those stimulated, respectively, by Epo plus IL-3 or GM-CSF and IL-3 plus GM-CSF, the results are consistent with the possibility that the suppressive effects of MIP-la are manifest on early, more immature, as opposed to the later, more mature, progenitors that are stimulated by single CSFs. This interpretation is consistent with a recent report by other investigators16 who demonstrated, using Cos cell supernatant rMIP-la and rMIP-10, that MIP-la, but not MIP-10, suppressed colony formation in vitro of an apparently early mouse progenitor (CFU-A) after direct addition of MIPs to plates. In addition, during ex vivo treatment of cells, these investigators found decreased cycling rates (percent cells in S-phase) of in vitro CFU-A and in vivo day 12 colony forming unit-spleen (CFU-S). Cells were from regenerating marrow and no effect was noted on numbers of CFU-S. While it is not clear how CFU-A and day 12 CFU-S relate to each other in terms of stem/progenitor cell hierarchy, these cells may be more immature than the CFU-GEMM and subpopulations of BFU-E and CFU-GM described in our report, which also respond to the suppressive action of nMIP and rMIP-la. Many cytokines are distinguished by multiple effects,' and it is apparent that this is also a characteristic of the MIP family of molecules. The direct enhancing and suppressing effects of the MIP preparations are both probably manifest on progenitors, but at different stages of maturity. Determination of the physiologic relevance of the myelopoietic enhancing and suppressing activities of MIP-1 and MIP-2 awaits the testing of these molecules in animal models. However, animal models and even human clinical trials with other hematopoietic growth factors (CSFs and ILs) have confirmed that the actions seen in vivo are what would have been predicted based on the actions of these molecules in vitro".'* and the MIP molecules were originally isolated based on their capacity to elicit an inflammatory response in v~v o .~.~ In this context it is of interest that heparin sulphate-bound molecules have been implicated in stromal cell-mediated hematopoiesis," since the MIPs are heparin-binding molecule^.^^^
